PINK:IGNE

Igene Biotechnology Stock Insider Trading

Basic Materials > Agricultural Inputs

Buy IGNE

*Your capital is at risk

$0.00001

+0 (+0%)

At Close: Jun 03, 2026

Igene Biotechnology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 862.91M and sold 343.09M IGNE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	862.91M shares
● Sell	343.09M shares
54% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 17, 2006 Sell	Common Stock S-Sale	Kempner Thomas L Director	Director	150 000 Value: $6K
Aug 17, 2006 Sell	Common Stock S-Sale	Kempner Thomas L Director	Director	150 000 Value: $6K
Aug 17, 2006 Buy	Common Stock P-Purchase	Kempner Thomas L Director	Director	10 000 Value: $400
Jun 28, 2006 Sell	Common Stock S-Sale	Kempner Thomas L Director	Director	200 000 Value: $8K
Jun 28, 2006 Sell	Common Stock S-Sale	Kempner Thomas L Director	Director	200 000 Value: $8K
Jun 28, 2006 Sell	Common Stock S-Sale	Kempner Thomas L Director	Director	200 000 Value: $8K
Jun 28, 2006 Sell	Common Stock S-Sale	Kempner Thomas L Director	Director	200 000 Value: $8K
Jun 15, 2006 Buy	Common Stock P-Purchase	Kempner Thomas L	Director	100 000 Value: $4K
Jun 15, 2006 Buy	Common Stock P-Purchase	Kempner Thomas L	Director	500 000 Value: $20.0K
Jun 15, 2006 Buy	Common Stock P-Purchase	Kempner Thomas L	Director	500 000 Value: $20.0K
Jun 15, 2006 Buy	Common Stock P-Purchase	Kempner Thomas L	Director	100 000 Value: $4K
Mar 23, 2006 Buy	8% Convertible Preferred Stock C-Conversion	Abeles Joseph C Resigned As Director 7/31/2002	Director	14 750 Value: $0
Mar 23, 2006 Buy	8% Convertible Preferred Stock C-Conversion	Abeles Joseph C Resigned As Director 7/31/2002	Director	14 750 Value: $0
Sep 12, 2005 Sell	Common Stock J-Other	Kempner Thomas L	Director	8 621 247 Value: $0
Sep 12, 2005 Sell	Convertible Debentures J-Other	Kempner Thomas L	Director	18 761 669 Value: $1.50M
Sep 12, 2005 Sell	Warrants J-Other	Kempner Thomas L	Director	41 561 125 Value: $3.12M
Sep 12, 2005 Sell	Warrants J-Other	Kempner Thomas L	Director	41 561 125 Value: $3.12M
Sep 12, 2005 Sell	Convertible Debentures J-Other	Kempner Thomas L	Director	18 761 669 Value: $1.50M
Sep 12, 2005 Sell	Common Stock J-Other	Kempner Thomas L	Director	8 621 247 Value: $0
Mar 26, 2003 Buy	Warrants A-Award	Kimelman Michael Director	Director	11 000 000 Value: $660.0K
Mar 26, 2003 Buy	Warrants A-Award	Kimelman Michael Director	Director	11 000 000 Value: $660.0K
Feb 28, 2002 Buy	Common Stock W-Will	Kempner Thomas L	Director	162 240 Value: $0
Feb 28, 2002 Buy	Warrants W-Will	Kempner Thomas L	Director	87 609 Value: $7K
Feb 28, 2002 Buy	Warrants W-Will	Kempner Thomas L	Director	87 609 Value: $7K
Feb 28, 2002 Buy	Common Stock W-Will	Kempner Thomas L	Director	162 240 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT IGENE BIOTECHNOLOGY INC

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial str...

Read Full Profile Here